Comment: The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 5, p. 626, doi. 10.1177/10600280211043505
- By:
- Publication type:
- Article
Works matching IS 10600280 AND DT 2022 AND VI 56 AND IP 5
Results: 15
1
2
Reply: The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 5, p. 628, doi. 10.1177/10600280211043188
- By:
- Publication type:
- Article
3
Primary Care Pharmacist Practice Models Shape the Comprehensive Medication Management Process.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 5, p. 620, doi. 10.1177/10600280211042031
- By:
- Publication type:
- Article
4
Ozanimod: A First-in-Class Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 5, p. 592, doi. 10.1177/10600280211041907
- By:
- Publication type:
- Article
5
Vericiguat: A Novel Oral Soluble Guanylate Cyclase Stimulator for the Treatment of Heart Failure.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 5, p. 600, doi. 10.1177/10600280211041384
- By:
- Publication type:
- Article
6
Rilonacept: A Newly Approved Treatment for Recurrent Pericarditis.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 5, p. 572, doi. 10.1177/10600280211036499
- By:
- Publication type:
- Article
7
Effectiveness and Safety of Twice- Versus Thrice-Daily Subcutaneous Heparin for Venous Thromboembolism Prophylaxis at a Large Academic Medical Center.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 5, p. 541, doi. 10.1177/10600280211041380
- By:
- Publication type:
- Article
8
Heparin Monitoring with an Anti-Xa Protocol Compared to Activated Clotting Time in Patients on Temporary Mechanical Circulatory Support.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 5, p. 513, doi. 10.1177/10600280211039582
- By:
- Publication type:
- Article
9
Proton Pump Inhibitors and the Risk of Community-Acquired Pneumonia: An Updated Meta-analysis.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 5, p. 524, doi. 10.1177/10600280211039240
- By:
- Publication type:
- Article
10
Incidence of Heparin-Induced Thrombocytopenia in Patients With Newly Implanted Mechanical Circulatory Support Devices.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 5, p. 565, doi. 10.1177/10600280211038705
- By:
- Publication type:
- Article
11
Budesonide/Glycopyrrolate/Formoterol Fumarate Co-suspension Metered Dose Inhaler: A Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 5, p. 582, doi. 10.1177/10600280211038353
- By:
- Publication type:
- Article
12
Impact of Pharmacist Activities in Patients With Depression: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 5, p. 556, doi. 10.1177/10600280211041274
- By:
- Publication type:
- Article
13
Outcome Benefits Seen With 1 Year of Optimized Sacubitril/Valsartan for the Treatment of Systolic Heart Failure Managed by Pharmacists in a Cardiology Practice.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 5, p. 548, doi. 10.1177/10600280211036149
- By:
- Publication type:
- Article
14
Brexucabtagene Autoleucel: A Novel Chimeric Antigen Receptor T-cell Therapy for the Treatment of Mantle Cell Lymphoma.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 5, p. 609, doi. 10.1177/10600280211026338
- By:
- Publication type:
- Article
15
Direct Oral Anticoagulants Versus Warfarin for Treatment of Thrombosis or Atrial Fibrillation in Patients With Cirrhosis: A Retrospective Cohort Study.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 5, p. 533, doi. 10.1177/10600280211025050
- By:
- Publication type:
- Article